This.
Rolling announcements on adult trials commencement, fda, potential clients, release of those results, further fda, other left field agreements ala MGH 2 year agreement (unless exclusive), potential FIL and sideline holdings increasing or coming into play; this story has many chapters yet to be revealed over the next 6 months. Whilst focusing on escrow there will be other contributing factors that may just influence what happens with those shares IMO.
This. Rolling announcements on adult trials commencement, fda,...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #